Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#How Has the Biguanides Market Growth Performance Trended Historically, And What Lies Ahead?#_x000D_

The size of the biguanides market has been experiencing steady growth over the past few years. The projected growth for this market is an increase from $4.96 billion in the year 2024 to about $5.11 billion in 2025, with a compound annual growth rate (CAGR) of 3.1%. The past growth can be traced back to several factors such as the increased need for oral hypoglycemic medication, expansion of the elderly population, a surge in obesity incidences, and heightened consciousness regarding diabetes control and care._x000D_

_x000D_

The biguanides market is poised for continuous growth in the coming years, with a projected increase to $5.81 billion in 2029, marking a compound annual growth rate (CAGR) of 3.2%. The predicted growth within this timeframe can be linked to factors such as the increased use of combination therapies, advancements in the technology behind drug delivery, an uplift in investment towards research and development, a rise in healthcare spending, and an extension in the use for treating polycystic ovary syndrome. Key trends for the prediction period includes greater emphasis on creating extended-release formulations, a rising preference for fixed-dose combination therapies, growing utilisation in the field of oncology, and the development of new biguanides with enhanced efficiency and safety features._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=15735&type=smp_x000D_

_x000D_

#What External and Internal Drivers Are Contributing to the Growth of theBiguanides Market?#_x000D_

The burgeoning rates of diabetes are projected to spur the expansion of the biguanides market in the future. Diabetes is a chronic metabolic anomaly marked by heightened blood sugar (glucose) levels due to the body’s insufficiency in insulin production. The escalation in diabetes cases can be attributed to a multitude of factors like lifestyle modifications, genetic predispositions, advanced diagnostic procedures, aging population, and environmental impacts. Biguanides, including metformin, address diabetes by enhancing insulin receptiveness, curbing glucose formation in the liver, and decreasing blood sugar levels in type 2 diabetes patients. For example, the Office for Health Improvement & Disparities, a UK government agency, reported in March 2024 that from March 2022 to March 2023, the proportion of individuals with type 1 diabetes receiving all eight advised care procedures surged by 22%, and for those with type 2 diabetes, it grew by 21%. Simultaneously, the percentage reaching the target HbA1c levels escalated to 37.9%, the highest figure ever documented. Therefore, the mounting instances of diabetes are fueling the growth of the biguanides market._x000D_

_x000D_

#What Segment Types Define the Biguanides Market Structure?#_x000D_

The biguanides market covered in this report is segmented – _x000D_

_x000D_

1) By Type: Metformin, Phenformin, Other Types_x000D_

2) By Dosage Form: Tablets, Oral Solutions_x000D_

3) By Formulation: Immediate Release, Extended Release_x000D_

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies_x000D_

_x000D_

Subsegments:_x000D_

1) By Metformin: Immediate-Release Metformin, Extended-Release Metformin _x000D_

2) By Phenformin: Phenformin Hydrochloride _x000D_

3) By Other Types: Buformin, Metformin Combinations_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=15735&type=smp_x000D_

_x000D_

#Which Geographic Areas Hold the Strongest Growth Potential in the Biguanides Market?#_x000D_

Asia-Pacific was the largest region in the biguanides market in 2024. Middle East And Africa is expected to be the fastest-growing region in the forecast period. The regions covered in the biguanides market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa._x000D_

_x000D_

#What Long-Term Trends Are Transforming the Competitive Landscape of the Biguanides Market?#_x000D_

Large businesses in the biguanide market are striving to create innovative solutions such as extended-release biguanide medicines in order to maximize patient adherence, increase treatment effectiveness, and minimize side effects. The extended-release biguanide drug is designed to release its active ingredient gradually, resulting in stable blood levels and improved glycemic control in diabetes patients, thus improving treatment compliance. Specifically, in August 2023, Dr. Reddy’s Laboratories, a biotech firm based in India, introduced extended-release medications of saxagliptin and metformin hydrochloride. This drug is a generic version of KOMBIGLYZE XR, which is endorsed by the US FDA, and it merges saxagliptin, a DPP-4 inhibitor, and metformin, a biguanide. It aims to improve the glycemic control in adults suffering from type 2 diabetes mellitus and is recommended to be used in conjunction with a healthy diet and regular exercise. The extended-release formulation of the drug assists in enhancing patient compliance and drug effectiveness._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/biguanides-global-market-report_x000D_

_x000D_

#What Is the Definition of the Biguanides Market?#_x000D_

Biguanides refer to a group of medications primarily used to treat type 2 diabetes. They help lower blood sugar levels by reducing the amount of sugar produced by the liver and improving the body’s response to insulin. These medications are also used to treat polycystic ovary syndrome (PCOS) and other metabolic disorders._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15735_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Europe +44 7882 955267_x000D_

Asia & Others +44 7882 955267 & +91 8897263534_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model